Lazard Asset Management LLC Immatics N.V. Transaction History
Lazard Asset Management LLC
- $68.3 Billion
- Q3 2024
A detailed history of Lazard Asset Management LLC transactions in Immatics N.V. stock. As of the latest transaction made, Lazard Asset Management LLC holds 87 shares of IMTX stock, worth $585. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87
Previous 1,544
94.37%
Holding current value
$585
Previous $17,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding IMTX
# of Institutions
101Shares Held
75.8MCall Options Held
238KPut Options Held
727K-
Rtw Investments, LP New York, NY10MShares$67.3 Million1.82% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$65.2 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$54.4 Million2.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.38MShares$49.7 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$43.4 Million0.79% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $513M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...